Number,

Medicine, 

Longevity.

We deliver high-accuracy AI-based predictions of clinical trial outcomes for all diseases.

 

We offer clinical-efficacy-prediction-based valuation of biopharma assets for all companies.

Sign up now to receive alerts of our upcoming clinical predictions!

Demiurge has achieved 87% accuracy in our 

prospective predictions of the phase 2 and phase 3 clinical trial results in 2020.

as of 7 August 2020

87%

Demiurge's prediction accuracy has beaten the weighted benchmark by a wide margin of +42%.   

as of 7 August 2020

+42%

Demiurge
Weighted
Benchmark
87%
45%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Prediction Accuracy

INDICATIONS

64

 Demiurge has made 150+ perspective predictions  covering 64 indications in 15 therapeutic areas. 

as of 7 August 2020

15

THERAPEUTIC ARES

logo front page.png

© 2015-2020 by Demiurge Technologies AG. All Rights Reserved.